CD8+ T cells are the major anti-tumor effector cells (Mami-Chouaib et al., 2018), and T cell-mediated antitumor immunity is strengthened by tumor-infiltrating B cells (Mami-Chouaib et al., 2018; Engelhard et al., 2021). This evidence concerns the gene CD8A and neoplasm.